Guardant Health
GH
168.33
-2.36
-1.38%
Guardant Health
US · GH
#820 by market cap
Listed 2018
168.33
-2.36
-1.38%
Live - 5344 symbols - heartbeat 389s ago
· 2026-10-08 07:03
Pre-market
168.33
0.00%
After-hours
168.33
0.00%
Overnight
167.98
-0.21%
- Market cap
- 22.59B
- P/E (TTM)i
- -47.96
- P/Bi
- -101.34
- EPSi
- -3.32
- Div yieldi
- 0.00%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on GH?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Wells Fargo Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $44Market Newswire · 2026/8/31
-
Bernstein Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $210Market Newswire · 2026/9/26
-
Barclays Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $200Market Newswire · 2026/9/18
-
Company notice
HHRG-WB (HHRG BHD): Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - GH CONSORTIUM SDN BHDBursa Malaysia · 2026/2/12
-
Analysts Are Bullish on These Healthcare Stocks: NeurAxis, Inc. (NRXS), Guardant Health (GH)TipRanks · 2026/9/16
-
Rating change
H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $65Market Newswire · 2026/8/10
-
Rating change
Piper Sandler Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $193Market Newswire · 2026/9/15
-
Company notice
GH Law Firm (Hangzhou) Legal Opinion on Hangzhou Silan Microelectronics Co., Ltd.'s Fourth Extraordinary General Meeting of Shareholders in 2024.SZSI · 2024/6/29
-
Rating change
William Blair Maintains Guardant Health(GH.US) With Buy RatingMarket Newswire · 2026/9/8
-
Goldman Sachs Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $225Market Newswire · 2026/9/21
-
Company notice
GH Research | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(12.9%),Peter Kolchinsky(12.9%), etc.SEC · 2024/11/15
-
Company notice
HHRG-WB (HHRG BHD): Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - GH CONSORTIUM SDN BHDBursa Malaysia · 2026/1/29
-
Rating change
CCORF Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39Market Newswire · 2026/8/8
-
Rating change
Rothschild & Co Redburn Initiates Guardant Health(GH.US) With Buy Rating, Announces Target Price $203Market Newswire · 2026/9/8
-
Rating change
BTIG Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $195Market Newswire · 2026/9/2
-
Rating change
Bernstein Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $210Market Newswire · 2026/9/9
-
Craig-Hallum Maintains Guardant Health(GH.US) With Buy RatingMarket Newswire · 2026/9/16
-
Rating change
Goldman Sachs Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $210Market Newswire · 2026/9/9
-
Rating change
Analysts Are Bullish on These Healthcare Stocks: Fractyl Health, Inc. (GUTS), Guardant Health (GH)TipRanks · 2026/9/2
-
Company notice
HHRG-WB (HHRG BHD): Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - GH CONSORTIUM SDN BHDBursa Malaysia · 2026/5/19
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 07:03:28 · For reference only, not investment advice and not tailored to your situation.